SPT Labtech and Agilent Technologies have announced the release of automated target enrichment protocols for the firefly®+ platform, designed to streamline genomic sequencing workflows in clinical research, oncology, and precision medicine applications. The protocols, which integrate Agilent’s SureSelect Max DNA Library Prep Kit with SPT Labtech’s liquid handling automation, are now available to all firefly+ […]

BioMed X has launched XFem Labs, a dedicated women’s health research and development accelerator at its Heidelberg facility, marking a strategic expansion of the institute’s translational research portfolio. The initiative, backed by a $2 million grant from the Gates Foundation, will focus on addressing critical gaps in women’s healthcare, with particular emphasis on accessible contraceptive […]

Italian researchers have demonstrated that immunoblot testing for anti-F-actin antibodies delivers diagnostic accuracy equivalent to established ELISA methods in autoimmune hepatitis type 1. The study reveals comparable specificity and overall performance metrics, potentially offering laboratories enhanced diagnostic flexibility for this rare but serious liver condition.

Bioscience will serve as the exclusive UK and Ireland distributor for Bio X Cell’s premium monoclonal antibody portfolio. The strategic partnership aims to enhance researcher access to high-quality functional antibodies across academic and biotech institutions throughout both regions.

German research institute BioMed X has announced a collaboration with Danish pharmaceutical giant Novo Nordisk to develop innovative oral formulation technologies for peptide drugs, including GLP-1 receptor agonists. The partnership aims to overcome critical barriers in oral peptide bioavailability through novel retention mechanisms in the lower small intestine. BioMed X, the independent biomedical research institute […]